Skip to main content
Clinical Trials/TCTR20210225002
TCTR20210225002
Completed
Not Applicable

Prediction score of hypoglycemia after administered an intravenous regular insulin with glucose for hyperkalemia treatment

Faculty of Medicine, Chiang Mai University0 sites200 target enrollmentFebruary 25, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hyperkalemia is one of important conditions that we should not underestimate it. Global prevalence of hyperkalemia is reported to be 5%. The current regimen of hyperkalemic patients is managed by 10 international units (IU) regular insulin with 25 grams glucose intravenously (IV) contributed to hypoglycemia. Hypoglycemia is a common complication of insulin treatment in hyperkalemic patients.
Sponsor
Faculty of Medicine, Chiang Mai University
Enrollment
200
Status
Completed
Last Updated
last year

Overview

Brief Summary

Background: We aimed to develop a predictive scoring model. Methods: A retrospective study was conducted. We included the hyperkalemic patients who were treated with 10 units of IV regular insulin with 25 g of glucose. Results: Three criteria were age more than 60 years old, pretreatment blood glucose 100 mg/dL or less, and pretreatment potassium more than 6 mmol/L. Conclusion: A high risk for posttreatment hypoglycemia was indicated if the patient met at least one of those criteria.

Registry
who.int
Start Date
February 25, 2021
End Date
June 30, 2021
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients who equal or more than 18 years old with diagnosed as hyperkalemia or serum potassium \> 5\.3 mmol/

Exclusion Criteria

  • Patients with incomplete of important data, pregnant

Outcomes

Primary Outcomes

Not specified

Similar Trials